Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLTG.L Regulatory News (BLTG)

  • There is currently no data for BLTG

Director/PDMR Shareholding

26 Jun 2007 07:02

Fonebak plc26 June 2007 Fonebak plc ("Fonebak" or the "Company") New Executive Plan Fonebak is pleased to announce the establishment of a new share incentive planfor its senior executives (the "Executive Plan"). Under the terms of the Executive Plan, the Company will issue new ordinaryshares ("Plan Shares") to the Fonebak employee benefit trust ("Fonebak EBT")which will sell an interest in the growth in value of the Plan Shares to certainFonebak senior executives. Fonebak EBT will be funded by a loan from theCompany. During the period of the Executive Plan, the Fonebak EBT will have theright to clawback the Plan Shares if, among other things, the relevant seniorexecutive leaves the Company other than as a good leaver or if the performancecriteria set out below are not fulfilled. The performance criteria under the Executive Plan are that, immediatelyfollowing the announcement of the Company's results for the period ending 30June 2010: • real annual growth in earnings per share for the Company, measured over a three year period from 1 July 2007 until 30 June 2010 is equal to or in excess of 5 per cent.; and • the market value of an ordinary share in the Company (as derived from AIM) is no less than twice the market value of a share at the close of business on 25 June 2007 (being 55.5 pence per share) In economic terms, the senior executives will be in a similar position to aholder of options at 55.5 pence per share. Under the terms of the Executive Plan: (i) an interest in 750,000 Plan Shares will held by Gary Stokes on 29 June 2007at a price of 55.5 pence per share, (750,000 shares representing approximately2.67 per cent. of the entire enlarged issued share capital of the Company); and (ii) an interest in 500,000 Plan Shares will be held by David Kelham on 29 June2007 at a price of 55.5 pence per share, (500,000 representing approximately1.78 per cent. of the entire enlarged issued share capital of the Company). Pursuant to the Executive Plan, 2,150,000 ordinary shares will be issuedrepresenting 8.28 per cent. of the existing share capital and 7.65 per cent. ofthe issued share capital as enlarged by this issue of ordinary shares.Application will be made for the 2,150,000 ordinary shares of 2 pence each to beadmitted to trading on AIM, such admission expected on 29 June 2007. Enquiries: Fonebak plcGary Stokes, Chief Executive +44 1865 487235 KBC Peel Hunt Ltd (Nominated Adviser) +44 20 7418 8900Jonathan MarrenOliver Stratton Pelham Public Relations +44 20 7743 6670James HendersonPhilip Dennis This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Oct 20185:41 pmRNSHolding(s) in Company
25th Sep 20187:00 amRNSFinal Results
27th Jul 20189:14 amRNSHolding(s) in Company
26th Jul 201811:00 amRNSDirector/PDMR Shareholding
11th Jul 20187:00 amRNSAppointment of Chief Financial Officer
11th Jul 20187:00 amRNSTrading Update and Notice of Results
29th Jun 20188:59 amRNSHolding(s) in Company
13th Jun 201812:16 pmRNSHolding(s) in Company
12th Jun 201812:28 pmRNSHolding(s) in Company
18th Apr 20182:40 pmRNSHolding(s) in Company
18th Apr 201812:05 pmRNSHolding(s) in Company
29th Mar 201811:40 amRNSDirector/PDMR Shareholding
28th Mar 20187:00 amRNSAppointment of Chief Executive Officer
26th Mar 201812:04 pmRNSHolding(s) in Company
22nd Mar 20182:27 pmRNSHolding(s) in Company
20th Mar 20187:11 amRNSHalf-year Report
9th Feb 201812:31 pmRNSDirector/PDMR Shareholding
19th Jan 201810:27 amRNSHolding(s) in Company
19th Jan 20187:00 amRNSTrading Update and Notice of Results
19th Dec 20175:35 pmRNSResult of AGM
24th Nov 20172:48 pmRNSPosting of Annual Report & Notice of AGM
8th Nov 20172:05 pmRNSSecond Price Monitoring Extn
8th Nov 20172:00 pmRNSPrice Monitoring Extension
7th Nov 20177:00 amRNSFinal Results
6th Nov 201710:25 amRNSHolding(s) in Company
3rd Nov 20175:03 pmRNSNotice of Results
13th Oct 20171:01 pmRNSHolding(s) in Company
2nd Oct 20177:00 amRNSPreparation of preliminary results
27th Sep 20173:58 pmRNSHolding(s) in Company
20th Sep 20175:54 pmRNSHolding(s) in Company
7th Sep 20177:00 amRNSBoard Update
4th Sep 20177:00 amRNSUpdates on revenue and management
3rd Aug 201712:37 pmRNSHolding(s) in Company
11th Jul 20173:33 pmRNSHolding(s) in Company
6th Jul 20177:00 amRNSTrading Statement
6th Jun 20173:16 pmRNSHolding(s) in Company
30th May 20177:00 amRNSDirectorate Change
16th May 20177:00 amRNSUpdate on Ordinary Shares
12th May 20173:53 pmRNSHolding(s) in Company
10th May 20173:34 pmRNSDirector/PDMR Shareholding
9th May 201712:27 pmRNSDirector/PDMR Shareholding
9th May 201712:26 pmRNSHolding(s) in Company
4th May 20177:00 amRNSResult of Placing
3rd May 20175:04 pmRNSProposed Placing
26th Apr 20176:01 pmRNSHolding(s) in Company
25th Apr 20177:00 amRNSQ3 Trading Update, Cash Flow Review and Funding
15th Mar 20172:55 pmRNSHolding(s) in Company
15th Mar 201711:27 amRNSDirector/PDMR Shareholding
15th Mar 20177:00 amRNSDirector/PDMR Shareholding
14th Mar 20172:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.